drugset / Trial / NCT06505187

Celecoxib for ENT Pain Management

NCT06505187

Phase 2 Recruiting 84 enrolled University of Wisconsin, Madison
RandomizedParallel-groupSingle-blindSupportive care

Summary

The goal of this clinical trial is to find out whether pain can be managed after an operation with celecoxib instead of oxycodone. The main question it aims to answer is if use of celecoxib plus Tylenol reduces the need for oxycodone. Researchers will compare the combination of celecoxib and Tylenol to a placebo to find out whether celecoxib works to manage pain. Participants will: * Take celecoxib, or a placebo, plus Tylenol with opioids as needed * Keep a diary of their pain between visits * Complete questionnaires

Timeline

Start
2025-02-28
Primary completion
2026-09
Completion
2026-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg
Background Acetaminophen Small molecule 650 mg
Background Oxycodone Other / unclassified 5 mg

Indications

No indication recorded.